Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Microsatellite Instability × Therapeutics × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Smoking Cessation 1 Microsatellite Instability 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Inflammatory Breast Neoplasms 1 Head and Neck Neoplasms 1 Dupuytren Contracture 1 Constriction, Pathologic 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

relatlimab 1 pembrolizumab 1 Therapeutics 1 Temozolomide 1 Nivolumab 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03519412 2026-03-03

ARETHUSA

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 2 Completed

107 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡